ClearOne, Inc. Reports First Quarter 2024 Financial Results
- Microphone revenue up 31% year over year-
-Revenue from
-Sequential and Year-over-Year OpEx Reductions Reflect Continued Benefits of Cost Optimization Initiatives -
“Revenue declined 12.8% sequentially and 13% year over year, primarily due to a significant decrease in revenues from the audio conferencing category, which includes our DSP mixer products. The revenue decline was regionally concentrated, affecting the
“In the first quarter, although overall revenue declined, there were some bright spots.” said
Operational Highlights
- Launched the DIALOG® 20 USB wireless microphone system at Integrated Systems Europe (ISE) 2024, a major global audiovisual expo. ClearOne’s booth at ISE 2024 recorded a 319% increase in unique visitors compared to the number of unique visitors the Company’s booth recorded in 2023. The DIALOG® UVHF Wireless Microphone System also received AV Technology Magazine’s Best in Show award at ISE 2024, having previously garnered other notable industry awards in 2023.
-
Announced a one-time special cash dividend of
$0.50 per share ofClearOne common stock, payable onApril 10, 2024 to shareholders of record onApril 2, 2024 . - Regained compliance with NASDAQ’s minimum bid requirement.
Graham continued: “Moving into the second quarter, we are working to build on the revenue growth we have experienced in
Financial Summary
The Company uses certain non-GAAP financial measures and reconciles those to GAAP measures in the attached tables.
● |
|
Q1 2024 revenue was |
|
|
|
● |
|
GAAP gross profit in Q1 2024 was |
|
|
|
● |
|
Operating expenses in Q1 2024 improved to |
|
|
|
● |
|
GAAP net loss in Q1 2024 was |
|
|
|
● |
|
Non-GAAP net loss in Q1 2024 was |
($ in 000, except per share) |
|
Three months ended |
|
|||||||
|
|
2024 |
|
|
|
2023 |
|
|
Change in % Favorable/(Adverse) |
|
GAAP |
|
|
|
|
|
|
|
|
|
|
Revenue |
$ |
3,622 |
|
|
$ |
4,178 |
|
|
(13 |
) |
Gross profit |
|
1,151 |
|
|
|
1,315 |
|
|
(12 |
) |
Operating expenses |
|
3,229 |
|
|
|
3,504 |
|
|
8 |
|
Operating loss |
|
(2,078 |
) |
|
|
(2,189 |
) |
|
5 |
|
Net loss |
|
(1,898 |
) |
|
|
(832 |
) |
|
(128 |
) |
Diluted loss per share |
|
(0.08 |
) |
|
|
(0.03 |
) |
|
(167 |
) |
Non-GAAP |
|
|
|
|
|
|
|
|
|
|
Non-GAAP operating expenses |
$ |
3,095 |
|
|
$ |
3,365 |
|
|
8 |
|
Non-GAAP operating loss |
|
(1,942 |
) |
|
|
(2,048 |
) |
|
5 |
|
Non-GAAP net loss |
|
(1,762 |
) |
|
|
(2,041 |
) |
|
14 |
|
Non-GAAP Adjusted EBITDA |
|
(1,764 |
) |
|
|
(1,678 |
) |
|
(5 |
) |
Non-GAAP diluted loss per share |
|
(0.07 |
) |
|
|
(0.09 |
) |
|
22 |
Balance Sheet Highlights
As of
About
Non-GAAP Financial Measures
To supplement our consolidated financial statements presented on a GAAP basis,
Forward Looking Statements
This release contains “forward-looking” statements that are based on present circumstances and on ClearOne’s predictions with respect to events that have not occurred, that may not occur, or that may occur with different consequences and timing than those now assumed or anticipated. Such forward-looking statements and any statements of the plans and objectives of management for future operations and forecasts of future growth and value are not guarantees of future performance or results and involve risks and uncertainties that could cause actual events or results to differ materially from the events or results described in the forward-looking statements. Such forward-looking statements are made only as of the date of this release and
In particular, the financial information contained herein is subject to and qualified by reference to the financial statements contained in the 10-Q, including the footnotes thereto, as well as the Company’s annual report on Form 10-K for the year ended
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS
(Dollars in thousands, except par value)
|
|
|
|
|
|
|
||
ASSETS |
|
|
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
18,544 |
|
|
$ |
17,835 |
|
Current marketable securities |
|
|
2,809 |
|
|
|
3,480 |
|
Patent cross license receivable |
|
|
— |
|
|
|
4,000 |
|
Receivables, net of allowance of |
|
|
2,794 |
|
|
|
3,279 |
|
Inventories, net |
|
|
11,434 |
|
|
|
10,625 |
|
Income tax receivable |
|
|
27 |
|
|
|
36 |
|
Prepaid expenses and other assets |
|
|
4,001 |
|
|
|
4,062 |
|
Total current assets |
|
|
39,609 |
|
|
|
43,317 |
|
Long-term marketable securities |
|
|
1,278 |
|
|
|
916 |
|
Long-term inventories, net |
|
|
4,161 |
|
|
|
3,143 |
|
Property and equipment, net |
|
|
542 |
|
|
|
530 |
|
Operating lease - right of use assets, net |
|
|
898 |
|
|
|
990 |
|
Intangibles, net |
|
|
1,615 |
|
|
|
1,689 |
|
Other assets |
|
|
108 |
|
|
|
109 |
|
Total assets |
|
$ |
48,211 |
|
|
$ |
50,694 |
|
LIABILITIES AND SHAREHOLDERS' EQUITY |
|
|
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
|
|
Accounts payable |
|
$ |
1,733 |
|
|
$ |
1,945 |
|
Dividends payable |
|
|
14,496 |
|
|
|
— |
|
Accrued liabilities |
|
|
1,959 |
|
|
|
2,290 |
|
Deferred product revenue |
|
|
26 |
|
|
|
30 |
|
Total current liabilities |
|
|
18,214 |
|
|
|
4,265 |
|
Operating lease liability, net of current |
|
|
574 |
|
|
|
665 |
|
Other long-term liabilities |
|
|
1,079 |
|
|
|
1,079 |
|
Total liabilities |
|
|
19,867 |
|
|
|
6,009 |
|
|
|
|
|
|
|
|
|
|
Shareholders' equity: |
|
|
|
|
|
|
|
|
Common stock, par value |
|
|
24 |
|
|
|
24 |
|
Additional paid-in capital |
|
|
31,584 |
|
|
|
46,047 |
|
Accumulated other comprehensive loss |
|
|
(290 |
) |
|
|
(310 |
) |
Accumulated deficit |
|
|
(2,974 |
) |
|
|
(1,076 |
) |
Total shareholders' equity |
|
|
28,344 |
|
|
|
44,685 |
|
Total liabilities and shareholders' equity |
|
$ |
48,211 |
|
|
$ |
50,694 |
|
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND
COMPREHENSIVE LOSS
(Dollars in thousands, except per share amounts)
|
|
Three months ended |
|
|||||
|
|
2024 |
|
|
2023 |
|
||
Revenue |
|
$ |
3,622 |
|
|
$ |
4,178 |
|
Cost of goods sold |
|
|
2,471 |
|
|
|
2,863 |
|
Gross profit |
|
|
1,151 |
|
|
|
1,315 |
|
|
|
|
|
|
|
|
|
|
Operating expenses: |
|
|
|
|
|
|
|
|
Sales and marketing |
|
|
1,312 |
|
|
|
1,192 |
|
Research and product development |
|
|
894 |
|
|
|
1,043 |
|
General and administrative |
|
|
1,023 |
|
|
|
1,269 |
|
Total operating expenses |
|
|
3,229 |
|
|
|
3,504 |
|
|
|
|
|
|
|
|
|
|
Operating loss |
|
|
(2,078 |
) |
|
|
(2,189 |
) |
|
|
|
|
|
|
|
|
|
Interest expense |
|
|
— |
|
|
(292 |
) |
|
Other income, net |
|
|
178 |
|
|
|
1,666 |
|
|
|
|
|
|
|
|
|
|
Loss before income taxes |
|
|
(1,900 |
) |
|
|
(815 |
) |
|
|
|
|
|
|
|
|
|
Provision for income taxes |
|
|
(2 |
) |
|
|
17 |
|
|
|
|
|
|
|
|
|
|
Net loss |
|
$ |
(1,898 |
) |
|
$ |
(832 |
) |
|
|
|
|
|
|
|
|
|
Basic weighted average shares outstanding |
|
|
23,969,148 |
|
|
|
23,955,767 |
|
Diluted weighted average shares outstanding |
|
|
23,969,148 |
|
|
|
23,955,767 |
|
|
|
|
|
|
|
|
|
|
Basic loss per share |
|
$ |
(0.08 |
) |
|
$ |
(0.03 |
) |
Diluted loss per share |
|
$ |
(0.08 |
) |
|
$ |
(0.03 |
) |
|
|
|
|
|
|
|
|
|
Comprehensive loss: |
|
|
|
|
|
|
|
|
Net loss |
|
$ |
(1,898 |
) |
|
$ |
(832 |
) |
Unrealized loss on available-for-sale securities, net of tax |
|
|
22 |
|
|
— |
|
|
Change in foreign currency translation adjustment |
|
|
(2 |
) |
|
|
5 |
|
Comprehensive loss |
|
$ |
(1,878 |
) |
|
$ |
(827 |
) |
UNAUDITED RECONCILIATION OF GAAP MEASURES TO NON-GAAP MEASURES
(Dollars in thousands, except per share values)
|
|
Three months ended |
|
|||||
|
|
2024 |
|
|
2023 |
|
||
GAAP operating loss |
|
$ |
(2,078 |
) |
|
$ |
(2,189 |
) |
Stock-based compensation |
|
|
26 |
|
|
|
23 |
|
Amortization of intangibles |
|
|
110 |
|
|
|
118 |
|
Non-GAAP operating loss |
|
$ |
(1,942 |
) |
|
$ |
(2,048 |
) |
|
|
|
|
|
|
|
|
|
GAAP net loss |
|
$ |
(1,898 |
) |
|
$ |
(832 |
) |
Stock-based compensation |
|
|
26 |
|
|
|
23 |
|
Amortization of intangibles |
|
|
110 |
|
|
|
118 |
|
Other income adjustment |
|
|
— |
|
|
|
(1,350 |
) |
Non-GAAP net loss |
|
$ |
(1,762 |
) |
|
$ |
(2,041 |
) |
|
|
|
|
|
|
|
|
|
GAAP net loss |
|
$ |
(1,898 |
) |
|
$ |
(832 |
) |
Number of shares used in computing GAAP diluted loss per share |
|
|
23,969,148 |
|
|
|
23,955,767 |
|
GAAP diluted loss per share |
|
$ |
(0.08 |
) |
|
$ |
(0.03 |
) |
Non-GAAP net loss |
|
$ |
(1,762 |
) |
|
$ |
(2,041 |
) |
Number of shares used in computing Non-GAAP diluted loss per share |
|
|
23,969,148 |
|
|
|
23,955,767 |
|
Non-GAAP diluted loss per share |
|
$ |
(0.07 |
) |
|
$ |
(0.09 |
) |
|
|
|
|
|
|
|
|
|
GAAP net loss |
|
$ |
(1,898 |
) |
|
$ |
(832 |
) |
Stock-based compensation |
|
|
26 |
|
|
|
23 |
|
Interest expense |
|
|
— |
|
|
|
292 |
|
Depreciation |
|
|
— |
|
|
|
54 |
|
Amortization of intangibles |
|
|
110 |
|
|
|
118 |
|
Other income adjustment |
|
|
— |
|
|
|
(1,350 |
) |
Provision for (benefit from) income taxes |
|
|
(2 |
) |
|
|
17 |
|
Non-GAAP Adjusted EBITDA |
|
$ |
(1,764 |
) |
|
$ |
(1,678 |
) |
View source version on businesswire.com: https://www.businesswire.com/news/home/20240520984276/en/
Investor Relations Contact:
385-426-0565
investor_relations@clearone.com
http://investors.clearone.com
Source: